This is prompted by the recent post by martingugino.
He "asked {his} hospital a question: 'In prostate cancer, is there a correlation between testosterone levels at diagnosis and Gleason score.'"
& received the expected answer "no correlation".
The people at the hospital would not be expected to have the hands-on experience to give an expert opinion, since testosterone [T] is not generally measured around the time of diagnosis.
(For the people who still believe that T drives PCa, "no correlation" must be a disappointing response.)
To answer the question, one would have to look at studies that did measure T at the time of diagnosis. Here are 16 studies since 2010:
[1] (2016) "Preoperative PSA/{free testosterone} index ratio is an independent strong factor which directly associates with aggressive features of pathology PCA"
[2] (2016) "Men with hypogonadism and a clinical indication for biopsy often have prostate cancer, many high grade. No men with an initial PSA rise on TRT had cancer."
[3] (2015) "Low Serum Testosterone ... Predicts High Gleason Score at Biopsy Diagnosed as Prostate Cancer in Patients with Serum PSA Lower than 20 ng/ml."
[4] (2015) "Preoperative low serum testosterone is associated with high-grade prostate cancer and an increased Gleason score upgrading"
[5] (2016) "low serum testosterone (<3.0 ng ml-1 , adjusted OR, 8.52 ...) predicted {extra-prostatic extension}"
[6] (2015) "Our data suggest that only low {bioavailable testosterone} and {free testosterone} levels, which might logically result in an active androgen-depleted environment, were linked with high-grade PCa."
[7] (2013) "Preoperative {total testosterone} was {inversely} associated with extraprostatic disease and may become a useful tool to improve our ability to recognize more advanced carcinomas. ... the concept that testosterone and other androgens have a permissive role and promote the development of PCa seems to be incorrect and an oversimplification in view of the current evidences in the field."
[8] (2012) "Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens"
[9] (2013) "Low pre-treatment fT levels were significantly associated with tumour stage and extraprostatic tumour spread and might-in addition or combination with PSA-serve as a useful prognostic parameter for prostate cancer patients prior to radical prostatectomy."
[10] (2012) "Association between low serum free testosterone and adverse prognostic factors in men diagnosed with prostate cancer"
[11] (2012) "Patients with PCa and lower testosterone levels have poor prognosis factors and higher tumour burden before treatment onset."
[12] (2011) "Lower serum total testosterone is associated with lymph node metastases in a radical prostatectomy cohort study."
[13] (2011) "High incidence of predominant Gleason pattern 4 localized prostate cancer is associated with low serum testosterone."
[14] (2011) "Low pretreatment serum testosterone levels correlate with a higher risk of {biochemical failure }"
[15] (2011) "Low serum testosterone appears to be predictive of aggressive disease (Gleason score >7 and extraprostatic disease, pathological stage > pT2) in patients who underwent RP for localized prostate cancer."
[16] (2010) "lower levels of {free testosterone} are detected in prostate cancer patients with extensive and high-grade disease."
-Patrick
[1] ncbi.nlm.nih.gov/pubmed/270...
[2] ncbi.nlm.nih.gov/pubmed/267...
[3] ncbi.nlm.nih.gov/pubmed/265...
[4] ncbi.nlm.nih.gov/pubmed/264...
[5] ncbi.nlm.nih.gov/pubmed/259...
[6] ncbi.nlm.nih.gov/pubmed/255...
[7] brazjurol.com.br/march_apri...
[8] ncbi.nlm.nih.gov/pubmed/229...
[9] ncbi.nlm.nih.gov/pubmed/227...
[10] ncbi.nlm.nih.gov/pubmed/226...
[11] ncbi.nlm.nih.gov/pubmed/225...
[12] ncbi.nlm.nih.gov/pubmed/219...
[13] ncbi.nlm.nih.gov/pubmed/218...
[14] "ncbi.nlm.nih.gov/pubmed/218...